| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 03/27/2013 | CN102988328A Method for preparing oral medicine for curing cancer, oral medicine for curing cancer and application thereof |
| 03/27/2013 | CN102988327A Mangiferin capsule and preparation method thereof |
| 03/27/2013 | CN102988320A Capecitabine dispersible tablet and preparation method thereof |
| 03/27/2013 | CN102988314A Lelrozol orally-disintegrating tablet and its preparation method |
| 03/27/2013 | CN102988313A Anastrozole dispersible tablet and preparation method thereof |
| 03/27/2013 | CN102988303A Preparation method of polyinosinic acid-polycytidylic acid lyophilized powder injection |
| 03/27/2013 | CN102988301A Preparation method of long-acting sustained-release microspheres containing bevacizumab |
| 03/27/2013 | CN102988296A Celecoxib solid dispersion and preparation method thereof |
| 03/27/2013 | CN102988293A Oxaliplatin folic acid targeted lipidosome and application thereof |
| 03/27/2013 | CN102988292A Gypenoside lipidosome consisting of sterol and preparation method thereof |
| 03/27/2013 | CN102988289A Preparation method for fat-soluble phtosensitizer nanoparticles and application thereof |
| 03/27/2013 | CN102988285A Docetaxel injection composition and preparation method thereof |
| 03/27/2013 | CN102988274A Sustained-release blood vessel embolic gel used for treating tumor, and preparation method thereof |
| 03/27/2013 | CN102986952A Spleen-strengthening phlegm-removing blood-activating anti-tumor tea and preparation method thereof |
| 03/27/2013 | CN102688317B Traditional Chinese medicine for treating liver cancer |
| 03/27/2013 | CN102526716B Preparation of specific tumor killing cell |
| 03/27/2013 | CN102499938B Agonist and application of Toll-like receptors 7 and 8 |
| 03/27/2013 | CN102499931B New application of disaccharide compound |
| 03/27/2013 | CN102336904B Multivalent polyglycol (PEG) modifier for camptothecin and derivatives thereof and application of multivalent PEG modifier |
| 03/27/2013 | CN102321158B Polypeptide for preventing cell DNA synthesis and inhibiting cell proliferation and application |
| 03/27/2013 | CN102319255B Anti-radiation spriulina polysaccharide organic bio-active iodine and application thereof |
| 03/27/2013 | CN102319243B Application of compound |
| 03/27/2013 | CN102309445B 多西他赛静脉注射组合物及其制备方法 Docetaxel intravenous composition and its preparation method |
| 03/27/2013 | CN102304555B Preparation method and application of antibiotics lobophorin A and lobophorin B |
| 03/27/2013 | CN102302737B Traditional Chinese medicine composition for treating gastric cancer |
| 03/27/2013 | CN102302460B Methylprednisolone sodium succinate freeze dried powder injection and preparation method thereof |
| 03/27/2013 | CN102294035B Dually-targeted anticancer nano-drug delivery system and preparation method thereof |
| 03/27/2013 | CN102286450B Technique for extracting active proteins from seashore mallow seeds and application thereof |
| 03/27/2013 | CN102284007B Medical liquid medicine for treating dermatoma by external application |
| 03/27/2013 | CN102283875B Composite containing eleutheroside active component and preparation method and applications thereof |
| 03/27/2013 | CN102274232B Application of adenosine receptor A1 antagonist in preparing medicine |
| 03/27/2013 | CN102274220B Use of sorafenib in preparing drugs for reversing multidrug resistance of tumors |
| 03/27/2013 | CN102258548B Method for preparing nardostachyos root and rhizome volatile oil beta-cyclodextrin inclusion compound |
| 03/27/2013 | CN102247581B Medicament for treating myoma of uterus |
| 03/27/2013 | CN102247502B Traditional Chinese medicine composition for treating breast cancer and preparation method thereof |
| 03/27/2013 | CN102247393B Preparation method of oleanolic acid saponin component and application thereof |
| 03/27/2013 | CN102232942B Antrodia camphorata cyclohexenone compound for suppressing growth of lymphoma tumor cells |
| 03/27/2013 | CN102232941B Antrodia camphorata cyclohexenone compound for inhibiting ovarian cancer tumor cell growth |
| 03/27/2013 | CN102232940B Antrodia camphorata cyclohexenone compound for inhibiting colorectal cancer tumor cell growth |
| 03/27/2013 | CN102225197B Application and extraction method of acrosin |
| 03/27/2013 | CN102218140B Tumor resistance effect of medicine combination of salvianolic acid B and coxib medicaments |
| 03/27/2013 | CN102198276B Application of chylomicron as liver targeting gene treatment vector |
| 03/27/2013 | CN102188424B Anti-leukemia effects of SR140333 |
| 03/27/2013 | CN102188394B Vinflunine freeze-drying medicinal composition |
| 03/27/2013 | CN102151329B Antitumor composition and preparation method thereof |
| 03/27/2013 | CN102140466B Human miR-1825 antisense nucleic acid and application thereof |
| 03/27/2013 | CN102127161B Antitumor polypeptide and application thereof |
| 03/27/2013 | CN102126938B Curcumin analog and preparation method and application thereof |
| 03/27/2013 | CN102125578B Rebeccamycin analogue with anticancer activity and synthesis method thereof |
| 03/27/2013 | CN102114044B Artificially processed bear bile powder and preparation method thereof |
| 03/27/2013 | CN102106966B Preparation method of Chinese medicinal composition with functions of supplementing qi and nourishing blood |
| 03/27/2013 | CN102050703B Resveratrol derivate as well as preparation method and application thereof |
| 03/27/2013 | CN102036955B Hydroxamate-based inhibitors of deacetylases b |
| 03/27/2013 | CN102031256B Human miR-485-5p antisense nucleic acid and application thereof |
| 03/27/2013 | CN102010366B 2,6-dichloro-5-fluoronicotinoyl fluorobenzene salicylamide compound as well as preparation and application thereof |
| 03/27/2013 | CN102000094B Ibandronic acid-containing medicinal composition and preparation process thereof |
| 03/27/2013 | CN101990442B Modified hydroxypolymer conjugates with bone seeking and tumor killing moieties |
| 03/27/2013 | CN101928347B Anti-carcinoembryonic-antigen (CEA) antibody and application thereof |
| 03/27/2013 | CN101921820B Preparation method of recombinant tumor specificity antiapoptotic factors with activity and application of products thereof |
| 03/27/2013 | CN101921772B Human antibodies that bind human IL-12 and methods for producing |
| 03/27/2013 | CN101912615B Cladribine formulations for improved oral and transmucosal delivery |
| 03/27/2013 | CN101906464B Proteins producing an altered immunogenic response and methods of making and using the same |
| 03/27/2013 | CN101897953B Non-invasive high-penetrability epidermal growth factor and application thereof |
| 03/27/2013 | CN101829199B Application of ranunculus japonicus extract in preparing anti-tumor and anti-tumor angiogenesis drugs |
| 03/27/2013 | CN101809002B Morpholino pyrimidine derivatives used in diseases linked to MTOR kinase and/or PI3K |
| 03/27/2013 | CN101808651B Polymer conjugate of steroid |
| 03/27/2013 | CN101787368B siRNA for restraining Z38 gene expression of human being and application thereof in preparing breast-tumor resisting medicine |
| 03/27/2013 | CN101768081B Inhibitor of fatty acid synthase and application thereof |
| 03/27/2013 | CN101757072B Method for enriching and purifying rhizoma atractylodis volatile oil in rhizoma atractylodis |
| 03/27/2013 | CN101607985B Monoclonal antibody for anti-human CEA, a composition containing same and application thereof |
| 03/27/2013 | CN101596307B Application of recombinant FN heparin binding domain polypeptide on preparing medicament resisting invasion and metastasis of malignant tumor |
| 03/27/2013 | CN101534860B Compositions and methods using anti-cs1 antibodies to treat multiple myeloma |
| 03/27/2013 | CN101528777B Antibody against RGD in amino acid sequence of extracellular matrix protein and production method and use of the same |
| 03/27/2013 | CN101528716B Compounds and methods for inhibiting the interaction of BCL proteins with binding partners |
| 03/27/2013 | CN101454311B Salt of phenoxypyridine derivative or crystal thereof and process for producing the same |
| 03/27/2013 | CN101429190B 4,5-disubstitutedphenyl-3H-1,2-disulphur heterocycle pentene-3-thioketone, -ketone, -ketoxime derivants and uses thereof |
| 03/27/2013 | CN101423513B Amine pyrimidine derivates, and production method thereof, and medicament composition and use |
| 03/27/2013 | CN101407459B Monohydroxy-2-acyl phenylacetate, and preparation and use thereof |
| 03/27/2013 | CN101384622B FGF2-binding peptides and uses thereof |
| 03/27/2013 | CN101381409B N-terminally chemically modified protein compositions and methods |
| 03/27/2013 | CN101293918B Shorten human papilloma virus 16 type L1 protein |
| 03/27/2013 | CN101291954B Modified antigen binding molecules with altered cell signaling activity |
| 03/27/2013 | CN101243056B Crystal of phenylalanine derivative, process for producing the same and use thereof |
| 03/27/2013 | CN101233117B Multidentate aza ligands able to complex metal ions and the use thereof in diagnostics and therapy |
| 03/27/2013 | CN101137623B N-sulphonylpyrroles and use thereof as histone deacetylase inhibitors |
| 03/27/2013 | CN101128427B Heterocyclic compounds as ccr2b antagonists |
| 03/27/2013 | CN101066997B Human antibodies that bind human IL-12 and methods for producing |
| 03/27/2013 | CN101023090B Prodrugs of HIV protease inhibitors |
| 03/26/2013 | US8404806 Isolated BRCA1 peptides and method of use |
| 03/26/2013 | US8404805 Characterization of GRP94-ligand interactions and purification, screening, and therapeutic methods relating thereto |
| 03/26/2013 | US8404802 a targeting vector which binds to receptors associated with integrin receptors, angiogenesis; contrast agents; diagnosis of malignant diseases, heart diseases, inflammation-related diseases, rheumatoid arthritis and Kaposi's sarcoma |
| 03/26/2013 | US8404738 4-amino-N-hydroxy-benzamides for the treatment of cancer |
| 03/26/2013 | US8404737 Substituted isoindoline-1,3-dione derivatives |
| 03/26/2013 | US8404700 Compounds modulating c-fms and/or c-kit activity and uses therefor |
| 03/26/2013 | US8404695 Pyrimidinyl pyridone inhibitors of JNK |
| 03/26/2013 | US8404685 Dihydropyrazole derivatives as tyrosine kinase modulators for the treatment of tumors |
| 03/26/2013 | US8404681 Xanthones, thioxanthones and acridinones as DNA-PK inhibitors |
| 03/26/2013 | US8404676 Oxadiazole diaryl compounds |
| 03/26/2013 | US8404674 Substituted 9H-purin-2-YL compounds, compositions thereof and uses thereof |
| 03/26/2013 | US8404667 2-methylene-19-nor-20(S)-1 alpha -hydroxy-bishomopregnacalciferol; 13-cis-retinoic acid activator; acne, psoriasis, ichthyosis, photoaging, photodamaged skin, skin cancer |